NEW YORK (GenomeWeb News) — IntegraGen today said it has established a US subsidiary and has hired former Roche Diagnostics executive Robert Gottlieb to be its new CEO.
The wholly-owned subsidiary, IntegraGen Inc., will be based in New York. Gottlieb will retain his role as vice president of global sales and marketing for the IntegraGen Group, which is located outside Paris.
Parent company Integragen uses gene-mapping products to develop molecular diagnostic products and operates a diagnostic and counseling center for diabetes in Bonn, Germany.
Gottlieb said the US division will begin plans to commercialize an undisclosed product in the US. The company said its diagnostic and gene-mapping efforts are currently targeted toward type-2 diabetes, obesity, autism, and bi-polar disorder.